Literature DB >> 18465817

Factorial design optimization and in vivo feasibility of poly(epsilon-caprolactone)-micro- and nanofiber-based small diameter vascular grafts.

B Nottelet1, E Pektok, D Mandracchia, J-C Tille, B Walpoth, R Gurny, M Möller.   

Abstract

Because of the severe increase of mortality by cardiovascular diseases, there has been rising interest among the tissue-engineering community for small-sized blood vessel substitutes. Here we present small diameter vascular grafts made of slow degradable poly(epsilon-caprolactone) nanofibers obtained by electrospinning. The process was optimized by a factorial design approach that led to reproducible grafts with inner diameters of 2 and 4 mm, respectively. Fiber sizes, graft morphology, and the resulting tensile stress and tensile strain values were studied as a function of various parameters in order to obtain optimal vascular grafts for implantation after gamma-sterilization. The influence of polymer concentration, solvent, needle-collector distance, applied voltage, flow rate, and spinning time has been studied. Consequently, an optimized vascular graft was implanted as an abdominal aortic substitute in nine rats for a feasibility study. Results are given following up a 12-week implantation period showing good patency, endothelization, and cell ingrowth. Copyright 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18465817     DOI: 10.1002/jbm.a.32023

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  29 in total

1.  Investigating thiol-modification on hyaluronan via carbodiimide chemistry using response surface methodology.

Authors:  Sruthi Santhanam; Jue Liang; Rinku Baid; Nathan Ravi
Journal:  J Biomed Mater Res A       Date:  2014-11-18       Impact factor: 4.396

Review 2.  Vascular organogenesis: dream or reality?

Authors:  Beat H Walpoth
Journal:  Organogenesis       Date:  2010 Jul-Sep       Impact factor: 2.500

Review 3.  [Tissue engineering of vascular prostheses].

Authors:  B H Walpoth; M Möller
Journal:  Chirurg       Date:  2011-04       Impact factor: 0.955

4.  Differential outcomes of venous and arterial tissue engineered vascular grafts highlight the importance of coupling long-term implantation studies with computational modeling.

Authors:  Cameron A Best; Jason M Szafron; Kevin A Rocco; Jacob Zbinden; Ethan W Dean; Mark W Maxfield; Hirotsugu Kurobe; Shuhei Tara; Paul S Bagi; Brooks V Udelsman; Ramak Khosravi; Tai Yi; Toshiharu Shinoka; Jay D Humphrey; Christopher K Breuer
Journal:  Acta Biomater       Date:  2019-06-12       Impact factor: 8.947

5.  Electrospun biodegradable elastic polyurethane scaffolds with dipyridamole release for small diameter vascular grafts.

Authors:  Primana Punnakitikashem; Danh Truong; Jyothi U Menon; Kytai T Nguyen; Yi Hong
Journal:  Acta Biomater       Date:  2014-08-08       Impact factor: 8.947

6.  Polymer nanofibrous structures: Fabrication, biofunctionalization, and cell interactions.

Authors:  Vince Beachley; Xuejun Wen
Journal:  Prog Polym Sci       Date:  2010-07-01       Impact factor: 29.190

7.  A small diameter, fibrous vascular conduit generated from a poly(ester urethane)urea and phospholipid polymer blend.

Authors:  Yi Hong; Sang-Ho Ye; Alejandro Nieponice; Lorenzo Soletti; David A Vorp; William R Wagner
Journal:  Biomaterials       Date:  2009-02-01       Impact factor: 12.479

Review 8.  Elastomers in vascular tissue engineering.

Authors:  Matti A Hiob; Gareth W Crouch; Anthony S Weiss
Journal:  Curr Opin Biotechnol       Date:  2016-05-02       Impact factor: 9.740

Review 9.  Quickening: Translational design of resorbable synthetic vascular grafts.

Authors:  Chelsea E T Stowell; Yadong Wang
Journal:  Biomaterials       Date:  2018-05-05       Impact factor: 12.479

10.  A biodegradable perivascular wrap for controlled, local and directed drug delivery.

Authors:  William G Sanders; Paul C Hogrebe; David W Grainger; Alfred K Cheung; Christi M Terry
Journal:  J Control Release       Date:  2012-04-27       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.